Medtech and Microcaps | Adu | Substack

What do Martin Shkreli, the co founder of 10 billion dollar pharma co., hedge funds and day traders have in common?

Aug 12, 2022

New Top Community

The turnaround is in its infancy, but has the ability to run

Jun 30, 2022

The device is great, but the trial results could disappoint.

Jun 16, 2022

Are you being Gaslit?, Thinking IS working, and reviewing Myomo, Performant, and Semler.

Apr 19, 2022

A long term stock limited by capacity, building a surgical platform with an exciting drug delivery business, new innovations on the horizon, too…

Apr 5, 2022

ZYXI was one of the biggest winners over the last five years nearly returning 100x: what did it look and feel like along the way?

Mar 1, 2022

Plus some thoughts on Specialists, Individual investors, PFMT, and NEPH

Feb 10, 2022

Boring isn't inactive, A New Add: $TRMR, Semler Update, 4 stocks on my watchlist: $BFIT, $NEPH, $LEE, $IDXG

Nov 4, 2021

Medtech and Microcaps

About Archive Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts